Fast-Track Your Medical Device, Pharma, and Biotech Products to the Brazilian Market
--
Clinical Studies: Accelerating Your Path to Market with GRINN
GRINN offers a wide range of clinical research services to accelerate your path to market while ensuring regulatory compliance. Our expertise spans various types of studies, designed to meet your product development needs.
Pre-Market Studies From Phase I to Phase III, our experienced team supports you throughout the entire clinical trial journey. We specialize in conducting critical Phase III studies that meet international regulatory standards, ensuring a smooth submission process tailored to the specific guidelines of each agency.
Post-Market Clinical Follow-Up (PMCF) Studies In addition to pre-market approval, GRINN provides long-term product support through Phase IV and PMCF studies. These flexible studies assess long-term safety and efficacy in real-world settings, providing valuable insights into product-related issues.
Pharmacovigilance Stay ahead of regulatory requirements with GRINN?s pharmacovigilance services. Our experts manage post-authorization safety studies (PASS) and efficacy studies (PAES), case processing, literature reviews, and signal detection. We also deliver periodic safety update reports (PSURs) in compliance, ensuring proactive risk management.
Benchmarking Studies Gain competitive insights with our customized benchmarking studies. These non-regulatory investigations help you optimize medical marketing strategies, identify innovation opportunities, and enhance production processes.
Count on GRINN to accelerate your clinical studies, navigate complex regulations, and unlock new market opportunities.
Contact us today by email: contact@grinn.co and find out how we can boost the success of your project.